Through study groups and exhibitions managed by TWOCELLS (the Hiroshima Meeting for Stem Cell Research and Advanced anti aging [AAA] study meeting), we specify the uniqueness of the seeds and propose project plans based on future prospects to our corporate clients.
After a contract is signed, we develop products utilizing the results of research and development of several years together with the licensing company.
After launching the product, we earn certain loyalty from the product sales revenue.
So far, we succeeded in the development of the serum-free culture medium STK® series, periodontal disease treatment products using BDNF, and the cartilage regeneration material TEC with MSCs.
We are also currently looking for licensors for several other intellectual properties.
We look for new seeds by attending study groups, exhibitions, and academic meetings.